Your browser doesn't support javascript.
loading
2'-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Modulating the Intestinal Microbiome.
Kim, Yeon-Ji; Kim, Han-Hae; Shin, Chul-Soo; Yoon, Jong-Won; Jeon, Seon-Min; Song, Young-Ha; Kim, Kwang-Youn; Kim, Kyungho.
Affiliation
  • Kim YJ; Korean Medicine (KM)-Application Center, Korea Institute of Oriental Medicine (KIOM), Daegu 41062, Republic of Korea.
  • Kim HH; Korean Medicine (KM)-Application Center, Korea Institute of Oriental Medicine (KIOM), Daegu 41062, Republic of Korea.
  • Shin CS; Advanced Protein Technologies Corp., Suwon 16229, Republic of Korea.
  • Yoon JW; Advanced Protein Technologies Corp., Suwon 16229, Republic of Korea.
  • Jeon SM; Advanced Protein Technologies Corp., Suwon 16229, Republic of Korea.
  • Song YH; Advanced Protein Technologies Corp., Suwon 16229, Republic of Korea.
  • Kim KY; Korean Medicine (KM)-Application Center, Korea Institute of Oriental Medicine (KIOM), Daegu 41062, Republic of Korea.
  • Kim K; Korean Medicine (KM)-Application Center, Korea Institute of Oriental Medicine (KIOM), Daegu 41062, Republic of Korea.
Nutrients ; 15(8)2023 Apr 12.
Article in En | MEDLINE | ID: mdl-37111064

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Colitis / Gastrointestinal Microbiome Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nutrients Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colitis, Ulcerative / Colitis / Gastrointestinal Microbiome Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Nutrients Year: 2023 Document type: Article